Back
Bio-Rad Laboratories Stock Price Chart

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
47
BIO
Bio-Rad Laboratories
Last Price:
$253.18
Seasonality Move:
0.08%
7 Day Trial
ALL ACCESS PASS
$
7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and BIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Bio-Rad Laboratories Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 239.68 | Buy |
20-day SMA: | 242.26 | Buy |
50-day SMA: | 245.73 | Buy |
200-day SMA: | 310.78 | Sell |
8-day EMA: | 242.44 | Buy |
20-day EMA: | 242.16 | Buy |
50-day EMA: | 253.96 | Buy |
200-day EMA: | 295.71 | Sell |
Bio-Rad Laboratories Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.69 | Sell |
Relative Strength Index (14 RSI): | 58.43 | Buy |
Chaikin Money Flow: | 324824 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (233.26 - 248.52) | Buy |
Bollinger Bands (100): | (241.43 - 334.59) | Sell |
Bio-Rad Laboratories Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Bio-Rad Laboratories Stock
Is Bio-Rad Laboratories Stock a Buy?
-
Bio-Rad Laboratories share price is 256.68 while BIO 8-day simple moving average is 239.68, which is a Buy signal.
-
The stock price of BIO is 256.68 while Bio-Rad Laboratories 20-day SMA is 242.26, which makes it a Buy.
-
Bio-Rad Laboratories 50-day simple moving average is 245.73 while BIO share price is 256.68, making it a Buy technically.
-
BIO stock price is 256.68 and Bio-Rad Laboratories 200-day simple moving average is 310.78, creating a Sell signal.
BIO Technical Analysis vs Fundamental Analysis
Sell
47
Bio-Rad Laboratories (BIO)
is a Sell
Is Bio-Rad Laboratories a Buy or a Sell?
-
Bio-Rad Laboratories stock is rated a SellThe current Bio-Rad Laboratories [BIO] share price is $256.68. The Score for BIO is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Bio-Rad Laboratories Stock Info
Market Cap:
7B
Price in USD:
256.68
Share Volume:
387.2K
Bio-Rad Laboratories 52-Week Range
52-Week High:
387.99
52-Week Low:
215.38
Sell
47
Bio-Rad Laboratories (BIO)
is a Sell
Bio-Rad Laboratories Share Price Forecast
-
What is the Bio-Rad Laboratories stock price today?The Bio-Rad Laboratories stock price is 256.68 USD today.
-
Will BIO stock go up or go down?Bio-Rad Laboratories> share price is forecast to RISE/FALL based on technical indicators
-
Is Bio-Rad Laboratories overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bio-Rad Laboratories is overvalued.
Is Bio-Rad Laboratories Stock a Buy?
-
Bio-Rad Laboratories share price is 256.68 while BIO 8-day exponential moving average is 242.44, which is a Buy signal.
-
The stock price of BIO is 256.68 while Bio-Rad Laboratories 20-day EMA is 242.16, which makes it a Buy.
-
Bio-Rad Laboratories 50-day exponential moving average is 253.96 while BIO share price is 256.68, making it a Buy technically.
-
BIO stock price is 256.68 and Bio-Rad Laboratories 200-day simple moving average is 295.71, creating a Sell signal.
Fundamental Analysis of Bio-Rad Laboratories
Is Bio-Rad Laboratories a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.65 per share, an increase next quarter of $0.56 per share, a decrease this year of $1.46 per share, and an increase next year of $0.87 per share.
Technical Analysis of Bio-Rad Laboratories
Should I short Bio-Rad Laboratories stock?
-
BIO Moving Average Covergence Divergence (MACD) indicator is -1.69, suggesting Bio-Rad Laboratories is a Sell
-
Bio-Rad Laboratories Relative Strength Index (RSI) is 58.43, which suggest Bio-Rad Laboratories is overbought
-
The Bollinger Bands (25) for Bio-Rad Laboratories is (233.26 - 248.52), which suggest Bio-Rad Laboratories is a Sell
-
The Bollinger Bands (100) for Bio-Rad Laboratories is (241.43 - 334.59), which suggest Bio-Rad Laboratories is a Sell
* Bio-Rad Laboratories stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.